Literature DB >> 8580374

Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women.

L Bélec1, R Gherardi, C Payan, T Prazuck, J E Malkin, C Tévi-Bénissan, J Pillot.   

Abstract

Proinflammatory cytokines may stimulate replication and spread of HIV. To evaluate to what extent the female genital tract represents a source of these cytokines, we determined TNF-alpha, IL-1 beta and IL-6 concentrations in paired serum and cervicovaginal washings from 45 HIV-negative and 50 HIV-positive women, and then we looked for the relevant mRNAs in cervicovaginal secretions by RT-PCR. Cytokines were detected by ELISA in cervicovaginal fluid from most healthy women. Cervicovaginal washing levels of TNF-alpha were increased above the control value +2 SD in 11/50 HIV-positive women, those of IL-1 beta in 13/50, and those of IL-6 in 14/50. The prevalences of TNF-alpha, IL-1 beta and IL-6 increase and their levels in cervicovaginal washings were significantly higher in the 20 patients at stage IV than in the 30 patients at earlier stages of the disease. In HIV-infected patients, serum and cervicovaginal washing levels correlated positively for TNF-alpha and IL-6, but not for IL-1 beta. Nine of 15 cytokine mRNAs determinations were positive in HIV-infected women versus 1 of 15 in controls (P < 0.01). These findings could be relevant to bidirectional heterosexual transmission of HIV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580374     DOI: 10.1006/cyto.1995.0077

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  14 in total

1.  Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Authors:  R N Fichorova; F Zhou; V Ratnam; V Atanassova; S Jiang; N Strick; A R Neurath
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 2.  Guiding the vaginal microbicide trials with biomarkers of inflammation.

Authors:  Raina N Fichorova
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10       Impact factor: 3.731

Review 3.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

4.  Changes to the cytokine microenvironment in the genital tract mucosa of HIV+ women.

Authors:  A Olaitan; M A Johnson; W M Reid; L W Poulter
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

5.  Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.

Authors:  L Bélec; C Tévi-Bénissan; T Dupré; A S Mohamed; T Prazuck; J Gilquin; J M Kanga; J Pillot
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

6.  Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells.

Authors:  Marie-Paule Carreno; Nicolas Chomont; Michel D Kazatchkine; Theano Irinopoulou; Corrine Krief; Ali-Si Mohamed; Laurent Andreoletti; Mathieu Matta; Laurent Belec
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women.

Authors:  Lindi Roberts; Jo-Ann S Passmore; Koleka Mlisana; Carolyn Williamson; Francesca Little; Lisa M Bebell; Gerhard Walzl; Melissa-Rose Abrahams; Zenda Woodman; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  J Infect Dis       Date:  2012-01-15       Impact factor: 5.226

8.  Development of an in vitro alternative assay method for vaginal irritation.

Authors:  Seyoum Ayehunie; Chris Cannon; Karen Larosa; Jeffrey Pudney; Deborah J Anderson; Mitchell Klausner
Journal:  Toxicology       Date:  2010-10-17       Impact factor: 4.221

9.  Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.

Authors:  Deborah J Anderson; D'Nyce L Williams; Susan A Ballagh; Kurt Barnhart; Mitchell D Creinin; Daniel R Newman; Frederick P Bowman; Joseph A Politch; Ann C Duerr; Denise J Jamieson
Journal:  Am J Reprod Immunol       Date:  2009-02       Impact factor: 3.886

10.  The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity.

Authors:  Maria Alice G Gonçalves; Edson G Soares; Eduardo A Donadi
Journal:  Infect Agent Cancer       Date:  2009-08-18       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.